Figure S4 from Phase I Dose-Escalation Trial of MIW815 (ADU-S100), an Intratumoral STING Agonist, in Patients with Advanced/Metastatic Solid Tumors or Lymphomas

Authors:
  • FMFunda Meric-Bernstam
    Funda Meric-Bernstam
  • FHF. Stephen Hodi
    F. Stephen Hodi
  • WMWells A. Messersmith
    Wells A. Messersmith
  • RARobert H.I. Andtbacka
    Robert H.I. Andtbacka
  • MIMatthew Ingham
    Matthew Ingham
  • NLNancy Lewis
    Nancy Lewis
  • XCXinhui Chen
    Xinhui Chen
  • MPMarc Pelletier
    Marc Pelletier
  • XCXueying Chen
    Xueying Chen
  • JWJincheng Wu
    Jincheng Wu
  • TDThomas W. Dubensky
    Thomas W. Dubensky

Abstract
On-treatment changes in NK-cell lineage markers in injected and noninjected lesions